BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 32755448)

  • 1. Role of metaplasia during gastric regeneration.
    Teal E; Dua-Awereh M; Hirshorn ST; Zavros Y
    Am J Physiol Cell Physiol; 2020 Dec; 319(6):C947-C954. PubMed ID: 32755448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44 variant isoform 9 emerges in response to injury and contributes to the regeneration of the gastric epithelium.
    Bertaux-Skeirik N; Wunderlich M; Teal E; Chakrabarti J; Biesiada J; Mahe M; Sundaram N; Gabre J; Hawkins J; Jian G; Engevik AC; Yang L; Wang J; Goldenring JR; Qualls JE; Medvedovic M; Helmrath MA; Diwan T; Mulloy JC; Zavros Y
    J Pathol; 2017 Aug; 242(4):463-475. PubMed ID: 28497484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystine/Glutamate Antiporter (xCT) Is Required for Chief Cell Plasticity After Gastric Injury.
    Meyer AR; Engevik AC; Willet SG; Williams JA; Zou Y; Massion PP; Mills JC; Choi E; Goldenring JR
    Cell Mol Gastroenterol Hepatol; 2019; 8(3):379-405. PubMed ID: 31071489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression of a putative progenitor cell marker DCAMKL1 in the rat gastric mucosa in regeneration, metaplasia and dysplasia.
    Kikuchi M; Nagata H; Watanabe N; Watanabe H; Tatemichi M; Hibi T
    BMC Gastroenterol; 2010 Jun; 10():65. PubMed ID: 20565818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Development of Spasmolytic Polypeptide/TFF2-Expressing Metaplasia (SPEM) During Gastric Repair Is Absent in the Aged Stomach.
    Engevik AC; Feng R; Choi E; White S; Bertaux-Skeirik N; Li J; Mahe MM; Aihara E; Yang L; DiPasquale B; Oh S; Engevik KA; Giraud AS; Montrose MH; Medvedovic M; Helmrath MA; Goldenring JR; Zavros Y
    Cell Mol Gastroenterol Hepatol; 2016 Sep; 2(5):605-624. PubMed ID: 27990460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia.
    Nam KT; Lee HJ; Mok H; Romero-Gallo J; Crowe JE; Peek RM; Goldenring JR
    Gastroenterology; 2009 Apr; 136(4):1288-96. PubMed ID: 19230855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease in MiR-148a Expression During Initiation of Chief Cell Transdifferentiation.
    Shimizu T; Sohn Y; Choi E; Petersen CP; Prasad N; Goldenring JR
    Cell Mol Gastroenterol Hepatol; 2020; 9(1):61-78. PubMed ID: 31473306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A molecular signature of gastric metaplasia arising in response to acute parietal cell loss.
    Nozaki K; Ogawa M; Williams JA; Lafleur BJ; Ng V; Drapkin RI; Mills JC; Konieczny SF; Nomura S; Goldenring JR
    Gastroenterology; 2008 Feb; 134(2):511-22. PubMed ID: 18242217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional role of CD44v-xCT system in the development of spasmolytic polypeptide-expressing metaplasia.
    Wada T; Ishimoto T; Seishima R; Tsuchihashi K; Yoshikawa M; Oshima H; Oshima M; Masuko T; Wright NA; Furuhashi S; Hirashima K; Baba H; Kitagawa Y; Saya H; Nagano O
    Cancer Sci; 2013 Oct; 104(10):1323-9. PubMed ID: 23848514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular Plasticity, Reprogramming, and Regeneration: Metaplasia in the Stomach and Beyond.
    Goldenring JR; Mills JC
    Gastroenterology; 2022 Feb; 162(2):415-430. PubMed ID: 34728185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deoxycholic acid-stimulated macrophage-derived exosomes promote spasmolytic polypeptide-expressing metaplasia in the stomach.
    Xu X; Cheng J; Luo S; Gong X; Huang D; Xu J; Qian Y; Wan X; Zhou H
    Biochem Biophys Res Commun; 2020 Apr; 524(3):649-655. PubMed ID: 32033746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injury, repair, inflammation and metaplasia in the stomach.
    Meyer AR; Goldenring JR
    J Physiol; 2018 Sep; 596(17):3861-3867. PubMed ID: 29427515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of spasmolytic polypeptide-expressing metaplasia with carcinogen administration and oxyntic atrophy in rats.
    Yamaguchi H; Goldenring JR; Kaminishi M; Lee JR
    Lab Invest; 2002 Aug; 82(8):1045-52. PubMed ID: 12177243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of oxyntic atrophy-induced gastric metaplasia in amphiregulin-deficient mice.
    Nam KT; Varro A; Coffey RJ; Goldenring JR
    Gastroenterology; 2007 May; 132(5):1804-19. PubMed ID: 17484876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell transcriptional analyses of spasmolytic polypeptide-expressing metaplasia arising from acute drug injury and chronic inflammation in the stomach.
    Bockerstett KA; Lewis SA; Wolf KJ; Noto CN; Jackson NM; Ford EL; Ahn TH; DiPaolo RJ
    Gut; 2020 Jun; 69(6):1027-1038. PubMed ID: 31481545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered metaplastic response of waved-2 EGF receptor mutant mice to acute oxyntic atrophy.
    Ogawa M; Nomura S; Varro A; Wang TC; Goldenring JR
    Am J Physiol Gastrointest Liver Physiol; 2006 Apr; 290(4):G793-804. PubMed ID: 16306133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current understanding of SPEM and its standing in the preneoplastic process.
    Weis VG; Goldenring JR
    Gastric Cancer; 2009; 12(4):189-97. PubMed ID: 20047123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxyntic atrophy, metaplasia, and gastric cancer.
    Goldenring JR; Nam KT
    Prog Mol Biol Transl Sci; 2010; 96():117-31. PubMed ID: 21075342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of the gastric mucosa III. Animal models of oxyntic atrophy and metaplasia.
    Goldenring JR; Nomura S
    Am J Physiol Gastrointest Liver Physiol; 2006 Dec; 291(6):G999-1004. PubMed ID: 17090722
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Li ML; Hong XX; Zhang WJ; Liang YZ; Cai TT; Xu YF; Pan HF; Kang JY; Guo SJ; Li HW
    World J Clin Cases; 2023 Jun; 11(16):3714-3724. PubMed ID: 37383139
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.